All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

331

Reset

331 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • HS-10542Phase 22 trials

    Jiangsu Hansoh Pharmaceutical Co., Ltd. · IgAN, Immunoglobulin A Nephropathy (IgAN), Glomerular Disease

  • HSK39297 300mgQDPhase 22 trials

    Haisco Pharmaceutical Group Co., Ltd. · IgA Nephropathy (IgAN), Lupus Nephritis (LN)

  • ICG318Phase 22 trials

    iCell Gene Therapeutics · Inflammatory Bowel Diseases (IBD), Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)

  • ImzokitugBMS-986340Phase 22 trials

    Bristol Myers Squibb · Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC), Cervical Cancer

  • IsuzinaxibAPX-115Phase 22 trials

    Aptabio Therapeutics, Inc. · Diabetic Kidney Disease (DKD), Contrast Induced Acute Kidney Injury

  • JMT108Phase 22 trials

    Shanghai JMT-Bio Inc. · Unresectable Locally Advanced or Metastatic Melanoma, Unresectable Locally Advanced or Metastatic Urinary Tract Tumors, Advanced Malignant Tumors

  • KN060Phase 22 trials

    Suzhou Alphamab Co., Ltd. · End-Stage Renal Disease Requiring Haemodialysis, Knee Arthroplasty, Total

  • MRT-2359Phase 22 trials

    Monte Rosa Therapeutics, Inc · Prostate Cancer, NSCLC, SCLC

  • NKX019Phase 22 trials

    Nkarta, Inc. · Lupus Nephritis, Primary Membranous Nephropathy, Systemic Sclerosis

  • QLH12016Phase 22 trials

    Qilu Pharmaceutical Co., Ltd. · Prostatic Neoplasms, Advanced Prostate Cancer

  • R2R01Phase 22 trials

    River 2 Renal Corp. · Acute Kidney Injury, Hepatorenal Syndrome

  • R3R01Phase 22 trials

    River 3 Renal Corp. · Diabetic Kidney Disease, Alport Syndrome, Focal Segmental Glomerulosclerosis

  • REGN4336Phase 22 trials

    Regeneron · Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)

  • REGN5459Vonsetamig, BCMAxCD3Phase 22 trials

    Regeneron · Chronic Kidney Disease (CKD), Relapsed Multiple Myeloma, Refractory Multiple Myeloma

  • SGB-9768Phase 22 trials

    Suzhou Sanegene Bio Inc. · PNH - Paroxysmal Nocturnal Hemoglobinuria, IgA Nephropathy (IgAN), C3 Glomerulopathy

  • SLN12140Phase 22 trials

    Linno Pharmaceuticals, Inc. · IgA Nephropathy (IgAN), Paroxysmal Nocturnal Hemoglobinuria (PNH)

  • SSS17Phase 22 trials

    Shenyang Sunshine Pharmaceutical Co., LTD. · Postoperative Anemia, Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee

  • STL303Phase 22 trials

    Sitala Bio LTD · IgAN, Geographic Atrophy

  • TTI-0102cysteamine-pantetheine disulfidePhase 22 trials

    Thiogenesis Therapeutics, Inc. · Nephropathic Cystinosis, Cystinosis, MELAS Syndrome

  • VNX001Phase 22 trials

    Vaneltix Pharma, Inc. · Interstitial Cystitis, Bladder Pain Syndrome

  • vudalimabPhase 22 trials

    Xencor, Inc. · Ovarian Cancer, Clear Cell Carcinoma, Endometrial Cancer

  • WGI-0301Phase 22 trials

    Zhejiang Haichang Biotech Co., Ltd. · Advanced Hepatocellular Carcinoma (HCC), Hepato Cellular Carcinoma (HCC), Renal Cell Cancer

  • XH-S003Phase 22 trials

    Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. · PNH - Paroxysmal Nocturnal Hemoglobinuria, IgA Nephropathy

  • ZalifrelimabPhase 22 trials

    ImmunoGenesis · Metastatic Prostate Cancer, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Cancer

  • ZEN003694ZEN-3694Phase 22 trials

    Zenith Epigenetics · mCRPC, Metastatic Castration-Resistant Prostate Cancer

  • AB-2100Integrated Circuit T cellsPhase 21 trial

    Arsenal Biosciences, Inc. · Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Recurrence

  • ACE-86225106Phase 21 trial

    Acerand Therapeutics (Shanghai) Limited · Solid Tumor, Adult, BRCA1 Mutation, BRCA2 Mutation

  • ADI-212Phase 21 trial

    Adicet Therapeutics · Prostate Cancer Metastatic

  • ADX-097Phase 21 trial

    Akebia Therapeutics · IgA Nephropathy, Lupus Nephritis (LN), C3 (Complement Component 3) Glomerulopathy

  • AGS 22M6EAGS-22CEPhase 21 trial

    Merck & Co. · Bladder Cancer

  • AIC263029Phase 21 trial

    AiCuris Anti-infective Cures AG · BK Virus Infection, BKV Infection, Kidney Transplant

  • AION-301Phase 21 trial

    AION Healthspan, Inc. · Chronic Kidney Disease Stage 3

  • ALXN1920Phase 21 trial

    AstraZeneca · Primary Membranous Nephropathy

  • ALXN2030Phase 21 trial

    AstraZeneca · Antibody-Mediated Rejection, Kidney Transplantation, Biopsy-proven Histologic Scores

  • AMO959BY1298, BY101298Phase 21 trial

    Novartis · PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy

  • AMXI-5001Phase 21 trial

    AtlasMedx, Incorporated · Advanced Malignant Neoplasm, Breast Cancer, Ovarian Cancer

  • AP306Phase 21 trial

    R1 Therapeutics · Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis, End Stage Renal Disease on Dialysis

  • APL-101Phase 21 trial

    Apollomics Inc. · Solid Tumors, Advanced Cancer, Renal Cancer

  • ARGX-121Phase 21 trial

    argenx · Immunoglobulin A Nephropathy (IgAN)

  • AS1986NSPhase 21 trial

    Antelope Surgical Solutions, Inc · Prostate Cancer, Prostate Cancer (Adenocarcinoma), Fluorescence Imaging

  • ASP5541PRL-02Phase 21 trial

    Astellas · Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer

  • AZD0516Phase 21 trial

    AstraZeneca · Metastatic Prostate Cancer

  • AZD0754Phase 21 trial

    AstraZeneca · Metastatic Prostate Cancer

  • AZD4144Phase 21 trial

    AstraZeneca · Sepsis, Acute Kidney Injury

  • AZD6621Phase 21 trial

    AstraZeneca · Prostate Cancer

  • AZD6750Phase 21 trial

    AstraZeneca · Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin)

  • AZD8359Phase 21 trial

    AstraZeneca · Metastatic Prostate Cancer

  • AZD9750Phase 21 trial

    AstraZeneca · Prostate Cancer

  • BAY3283142Phase 21 trial

    Bayer · Chronic Kidney Disease

  • CC-38Phase 21 trial

    CuraCell TX AB · Metastatic Colorectal Cancer, Prostate Cancer Metastatic, Prostate Cancer Locally Advanced

NewerPage 5 of 7Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.